Form 8-K - Current report:
SEC Accession No. 0001104659-19-058050
Filing Date
2019-10-31
Accepted
2019-10-31 06:31:47
Documents
15
Period of Report
2019-10-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1921493d1_8k.htm   iXBRL 8-K 36977
2 EXHIBIT 99.1 tm1921493d1_ex99-1.htm EX-99.1 914435
6 GRAPHIC tm1921493-1_8kimg01.jpg GRAPHIC 3987
7 GRAPHIC idexxlaboratoriesinc.jpg GRAPHIC 14875
  Complete submission text file 0001104659-19-058050.txt   1195108

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA idxx-20191031.xsd EX-101.SCH 3177
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE idxx-20191031_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idxx-20191031_pre.xml EX-101.PRE 22704
10 EXTRACTED XBRL INSTANCE DOCUMENT tm1921493d1_8k_htm.xml XML 3496
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19271 | Film No.: 191182004
SIC: 2835 In Vitro & In Vivo Diagnostic Substances